AlphaTON Capital Stock (NASDAQ:ATON)


Chart

Previous Close

$5.67

52W Range

$2.95 - $23.01

50D Avg

$6.84

200D Avg

$6.16

Market Cap

$12.80M

Avg Vol (3M)

$120.04K

Beta

0.64

Div Yield

-

ATON Company Profile


AlphaTON Capital Corp. is the rebranded entity formerly known as Portage Biotech Inc., a clinical-stage immuno-oncology company transitioning into a digital asset treasury model focused on accumulating and staking Toncoin (TON). AlphaTON intends to invest significantly in TON tokens, targeting a Long-Term TON treasury of approximately US $100 million.

Show More

Industry

Asset Management

Sector

Financial Services

Exchange

NASDAQ

ADR

-

Country

US

Employees

4

IPO Date

Jan 02, 2002

Website

ATON Performance


Peer Comparison


TickerCompany
BDRXBiodexa Pharmaceuticals Plc
BHVNBiohaven Ltd.
TNONTenon Medical, Inc.
VRAXVirax Biolabs Group Limited
STSSSharps Technology, Inc.
INBXInhibrx Biosciences, Inc.
KTTAPasithea Therapeutics Corp.
IMNMImmunome, Inc.